Frederik Barfoed Beck is the Senior Outsourcing Manager at Zealand Pharma A/S.
Dr. Frederik Beck has more than 25 years of experience from pharmaceutical and biotech companies. He is the Senior Outsourcing Manager at Zealand Pharma and has held this position for the past twelve years and has successfully completed 2 IMPD s for two new chemical entities as well as been part of bringing Zegalogue, Zealand Pharma’s product for treatment of severe acute hypoglycemia to market. As Senior Outsourcing Manager Dr. Beck is responsible for the outsourcing of all activities relating to clinical trials, both DS, DP and medical device.
Prior to joining Zealand Pharma Dr. Beck worked for CMC Biologics as Project Director and as scientist/ project manager at Hexal.
Dr. Beck received a Master of Chemical Engineering in 1992 from the Technical University of Denmark and an industrial Ph.D. from the University of Copenhagen in collaboration with DAKO A/S.
Dr. Beck is a member of the Board of Directors at Zealand Pharma.
Presentation Title: Dasiglucagon: The Journey from Compound to Commercial Product
Abstract: A presentation of the discovery and development of the proprietary Zealand Pharma molecule Dasiglucagon, all the way to commercialization of the combination product.
Dasiglucagon is a glucagon analogue developed by Zealand by Zealand Pharma for the treatment of severe acute hypoglycemia.